{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:50:57Z","timestamp":1791453057329,"version":"4.3.3"},"reference-count":51,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Perinatol"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Objectives<\/jats:title>\n                    <jats:p>To compare growth z-scores and prematurity-related comorbidities for preterm infants receiving Soybean Oil-Intravenous Lipid Emulsion (SO-ILE) versus Soybean\u2009+\u2009Medium-chain triglycerides\u2009+\u2009Olive\u2009+\u2009Fish oil ILE (SMOF-ILE).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Study design<\/jats:title>\n                    <jats:p>A multicenter, retrospective cohort study of 347 preterm infants &lt;32 weeks\u2019 gestational age with birth weight \u22641500 grams who received SO-ILE or SMOF-ILE for at least seven consecutive days.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      SO-ILE group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009179) demonstrated significantly improved growth for length (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009\u2264\u20090.001) and head circumference z-scores (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.015) at 36 weeks\u2019 postmenstrual age and significantly worse growth for weight z-scores at 1 month (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.017) compared to the SMOF-ILE group (\n                      <jats:italic>n<\/jats:italic>\n                      \u2009=\u2009168). SO-ILE group had significantly lower rates of bronchopulmonary dysplasia (BPD) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u20090.001) and urinary tract infections (UTI) (\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u20090.045).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>In this population, SO-ILE had better outcomes for growth, BPD, and UTI compared to SMOF-ILE. Therefore, SO-ILE remains a reasonable lipid emulsion for preterm infants until more evidence is available.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1038\/s41372-026-02865-w","type":"journal-article","created":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T08:02:19Z","timestamp":1791446539000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparison of growth and morbidity outcomes in preterm infants using two different intravenous lipid emulsions"],"prefix":"10.1038","author":[{"given":"Alexyss","family":"Guy","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Austin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Kwiatkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0002-8309-5692","authenticated-orcid":false,"given":"Anna C.","family":"Felmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel H.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrita","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Gothard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4588-3412","authenticated-orcid":false,"given":"Rita M.","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4357-0308","authenticated-orcid":false,"given":"Jaime","family":"Marasch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0768-1887","authenticated-orcid":false,"given":"Zeyar T.","family":"Htun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,10,8]]},"reference":[{"key":"2865_CR1","doi-asserted-by":"publisher","first-page":"25","DOI":"10.4137\/CMPed.S21161","volume":"9","author":"GS Salama","year":"2015","unstructured":"Salama GS, Kaabneh MA, Almasaeed MN, Alquran M. Intravenous lipids for preterm infants: a review. Clin Med Insights Pediatr. 2015;9:25\u201336.","journal-title":"Clin Med Insights Pediatr"},{"key":"2865_CR2","doi-asserted-by":"publisher","first-page":"18s","DOI":"10.1177\/0148607115595980","volume":"39","author":"PC Calder","year":"2015","unstructured":"Calder PC. Functional roles of fatty acids and their effects on human health. JPEN J Parenter Enter Nutr. 2015;39:18s\u201332s.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2865_CR3","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/j.clp.2014.02.007","volume":"41","author":"CR Martin","year":"2014","unstructured":"Martin CR. Fatty acid requirements in preterm infants and their role in health and disease. Clin Perinatol. 2014;41:363\u201382.","journal-title":"Clin Perinatol"},{"key":"2865_CR4","doi-asserted-by":"publisher","first-page":"697","DOI":"10.1002\/jpen.1537","volume":"43","author":"L Gramlich","year":"2019","unstructured":"Gramlich L, Ireton-Jones C, Miles JM, Morrison M, Pontes-Arruda A. Essential fatty acid requirements and intravenous lipid emulsions. JPEN J Parenter Enter Nutr. 2019;43:697\u2013707.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2865_CR5","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1002\/jpen.2422","volume":"47","author":"KA Huff","year":"2023","unstructured":"Huff KA, Nayak SP, Ahmad I, DiGeronimo R, Hair A, Kim JH, et al. Patterns of lipid-injectable emulsion use in neonatal intensive care units across the United States: a multi-institution survey. J Parenter Enter Nutr. 2023;47:51\u20138.","journal-title":"J Parenter Enter Nutr"},{"key":"2865_CR6","first-page":"129","volume":"28","author":"J Greenberg","year":"2023","unstructured":"Greenberg J, Naik M, Chapman J, Davidson A, Imseis E. Comparison of two lipid emulsions on the incidence of parenteral nutrition associated cholestasis in neonates. J Pediatr Pharm Ther. 2023;28:129\u201335.","journal-title":"J Pediatr Pharm Ther"},{"key":"2865_CR7","doi-asserted-by":"crossref","unstructured":"Guthrie G, Burrin D. Impact of parenteral lipid emulsion components on cholestatic liver disease in neonates. Nutrients. 2021;13:508.","DOI":"10.3390\/nu13020508"},{"key":"2865_CR8","doi-asserted-by":"crossref","unstructured":"Hellstr\u00f6m A, Hellstr\u00f6m W, Hellgren G, LEHS, Puttonen H, Fyhr IM, et al. Docosahexaenoic acid and arachidonic acid levels are associated with early systemic inflammation in extremely preterm infants. Nutrients. 2020;12:1996.","DOI":"10.3390\/nu12071996"},{"key":"2865_CR9","doi-asserted-by":"publisher","first-page":"743","DOI":"10.1016\/j.jpeds.2011.04.039","volume":"159","author":"CR Martin","year":"2011","unstructured":"Martin CR, Dasilva DA, Cluette-Brown JE, Dimonda C, Hamill A, Bhutta AQ, et al. Decreased postnatal docosahexaenoic and arachidonic acid blood levels in premature infants are associated with neonatal morbidities. J Pediatr. 2011;159:743\u20139.e741-2.","journal-title":"J Pediatr"},{"key":"2865_CR10","unstructured":"FDA Office of Clinical Pharmacology Review. 2022. https:\/\/www.fda.gov\/media\/158295\/download#:~:text=Smoflipid%2020%25%20."},{"key":"2865_CR11","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1177\/0148607106030004351","volume":"30","author":"DL Waitzberg","year":"2006","unstructured":"Waitzberg DL, Torrinhas RS, Jacintho TM. New parenteral lipid emulsions for clinical use. JPEN J Parenter Enter Nutr. 2006;30:351\u201367.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2865_CR12","doi-asserted-by":"publisher","DOI":"10.3389\/fphar.2021.723040","volume":"12","author":"RM Bilal","year":"2021","unstructured":"Bilal RM, Liu C, Zhao H, Wang Y, Farag MR, Alagawany M, et al. Olive oil: nutritional applications, beneficial health aspects and its prospective application in poultry production. Front Pharm. 2021;12:723040.","journal-title":"Front Pharm"},{"key":"2865_CR13","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1016\/j.jpedsurg.2019.09.073","volume":"55","author":"C Casson","year":"2020","unstructured":"Casson C, Nguyen V, Nayak P, Channabasappa N, Berris K, Panczuk J, et al. A comparison of Smoflipid\u00ae and Intralipid\u00ae in the early management of infants with intestinal failure. J Pediatr Surg. 2020;55:153\u20137.","journal-title":"J Pediatr Surg"},{"key":"2865_CR14","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1002\/jpen.1843","volume":"45","author":"RL Jackson","year":"2021","unstructured":"Jackson RL, White PZ, Zalla J. SMO flipid vs intralipid 20%: effect of mixed-oil vs soybean-oil emulsion on parenteral nutrition-associated cholestasis in the neonatal population. JPEN J Parenter Enter Nutr. 2021;45:339\u201346.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2865_CR15","doi-asserted-by":"publisher","first-page":"120","DOI":"10.1542\/peds.2014-0459","volume":"134","author":"P Zhang","year":"2014","unstructured":"Zhang P, Lavoie PM, Lacaze-Masmonteil T, Rhainds M, Marc I. Omega-3 long-chain polyunsaturated fatty acids for extremely preterm infants: a systematic review. Pediatrics. 2014;134:120\u201334.","journal-title":"Pediatrics"},{"key":"2865_CR16","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/j.clnu.2018.06.929","volume":"38","author":"CC Hsiao","year":"2019","unstructured":"Hsiao CC, Lin HC, Chang YJ, Yang SP, Tsao LY, Lee CH, et al. Intravenous fish oil containing lipid emulsion attenuates inflammatory cytokines and the development of bronchopulmonary dysplasia in very premature infants: a double-blind, randomized controlled trial. Clin Nutr. 2019;38:1045\u201352.","journal-title":"Clin Nutr"},{"key":"2865_CR17","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1177\/0884533615602011","volume":"31","author":"M Skouroliakou","year":"2016","unstructured":"Skouroliakou M, Konstantinou D, Agakidis C, Kaliora A, Kalogeropoulos N, Massara P, et al. Parenteral MCT\/\u03c9-3 polyunsaturated fatty acid-enriched intravenous fat emulsion is associated with cytokine and fatty acid profiles consistent with attenuated inflammatory response in preterm neonates: a randomized, double-blind clinical trial. Nutr Clin Pr. 2016;31:235\u201344.","journal-title":"Nutr Clin Pr"},{"key":"2865_CR18","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1002\/ncp.11278","volume":"40","author":"J Wolff","year":"2025","unstructured":"Wolff J, Cober MP, Huff KA. Essential fatty acid deficiency in parenteral nutrition: historical perspective and modern solutions, a narrative review. Nutr Clin Pract. 2025;40:350\u201367.","journal-title":"Nutr Clin Pract"},{"key":"2865_CR19","doi-asserted-by":"publisher","first-page":"676","DOI":"10.1136\/archdischild-2020-319108","volume":"106","author":"LC Frazer","year":"2021","unstructured":"Frazer LC, Martin CR. Parenteral lipid emulsions in the preterm infant: current issues and controversies. Arch Dis Child Fetal Neonatal Ed. 2021;106:676\u201381.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2865_CR20","doi-asserted-by":"publisher","first-page":"1431","DOI":"10.1016\/S0022-2275(20)41397-5","volume":"33","author":"D Rubin","year":"1992","unstructured":"Rubin D, Laposata M. Cellular interactions between n-6 and n-3 fatty acids: a mass analysis of fatty acid elongation\/desaturation, distribution among complex lipids, and conversion to eicosanoids. J Lipid Res. 1992;33:1431\u201340.","journal-title":"J Lipid Res"},{"key":"2865_CR21","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1016\/j.clnesp.2017.04.004","volume":"20","author":"S Najm","year":"2017","unstructured":"Najm S, L\u00f6fqvist C, Hellgren G, Engstr\u00f6m E, Lundgren P, H\u00e5rd AL, et al. Effects of a lipid emulsion containing fish oil on polyunsaturated fatty acid profiles, growth and morbidities in extremely premature infants: a randomized controlled trial. Clin Nutr ESPEN. 2017;20:17\u201323.","journal-title":"Clin Nutr ESPEN"},{"key":"2865_CR22","doi-asserted-by":"publisher","first-page":"216","DOI":"10.3390\/nu8040216","volume":"8","author":"KB Hadley","year":"2016","unstructured":"Hadley KB, Ryan AS, Forsyth S, Gautier S, Salem N Jr. The essentiality of arachidonic acid in infant development. Nutrients. 2016;8:216.","journal-title":"Nutrients"},{"key":"2865_CR23","doi-asserted-by":"publisher","first-page":"8","DOI":"10.1016\/j.siny.2016.08.009","volume":"22","author":"DT Robinson","year":"2017","unstructured":"Robinson DT, Martin CR. Fatty acid requirements for the preterm infant. Semin Fetal Neonatal Med. 2017;22:8\u201314.","journal-title":"Semin Fetal Neonatal Med"},{"key":"2865_CR24","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1055\/s-0039-1701026","volume":"38","author":"J Uberos","year":"2021","unstructured":"Uberos J, Jim\u00e9nez-Montilla S, Molina-Oya M, Nieto-G\u00f3mez P, Millan IC. Morbidity outcomes of very low birth weight neonates receiving parenteral nutrition with fish oil enriched lipid emulsion or lipid emulsion with soybean oil: an observational study. Am J Perinatol. 2021;38:952\u20139.","journal-title":"Am J Perinatol"},{"key":"2865_CR25","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1007\/s00431-018-3112-3","volume":"177","author":"N Choudhary","year":"2018","unstructured":"Choudhary N, Tan K, Malhotra A. Inpatient outcomes of preterm infants receiving \u03c9-3 enriched lipid emulsion (SMOFlipid): an observational study. Eur J Pediatr. 2018;177:723\u201331.","journal-title":"Eur J Pediatr"},{"key":"2865_CR26","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1002\/jpen.1968","volume":"45","author":"S Costa","year":"2021","unstructured":"Costa S, Cocca C, Barone G, Catenazzi P, Gallini F, Maggio L, et al. Growth of head circumference and body length in preterm infants receiving a multicomponent vs a soybean-based lipid emulsion: a randomized controlled trial. JPEN J Parenter Enter Nutr. 2021;45:94\u2013101.","journal-title":"JPEN J Parenter Enter Nutr"},{"key":"2865_CR27","doi-asserted-by":"crossref","unstructured":"Asfour SS, Alshaikh B, AlMahmoud L, Sumaily HH, Alodhaidan NA, Alkhourmi M, et al. SMO flipid impact on growth and neonatal morbidities in very preterm infants. Nutrients. 2022;14:3952.","DOI":"10.3390\/nu14193952"},{"key":"2865_CR28","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1186\/1471-2431-13-59","volume":"13","author":"TR Fenton","year":"2013","unstructured":"Fenton TR, Kim JH. A systematic review and meta-analysis to revise the Fenton growth chart for preterm infants. BMC Pediatr. 2013;13:59.","journal-title":"BMC Pediatr"},{"key":"2865_CR29","first-page":"83","volume":"28","author":"R Harb","year":"2007","unstructured":"Harb R, Thomas DW. Conjugated hyperbilirubinemia. Screen Treat older infants Child Pediatr Rev. 2007;28:83\u201391.","journal-title":"Screen Treat older infants Child Pediatr Rev"},{"key":"2865_CR30","doi-asserted-by":"publisher","first-page":"751","DOI":"10.1164\/rccm.201812-2348OC","volume":"200","author":"EA Jensen","year":"2019","unstructured":"Jensen EA, Dysart K, Gantz MG, McDonald S, Bamat NA, Keszler M, et al. The diagnosis of bronchopulmonary dysplasia in very preterm infants. an evidence-based approach. Am J Respir Crit Care Med. 2019;200:751\u20139.","journal-title":"Am J Respir Crit Care Med"},{"key":"2865_CR31","doi-asserted-by":"publisher","first-page":"133","DOI":"10.3233\/NPM-15814099","volume":"8","author":"P Holtrop","year":"2015","unstructured":"Holtrop P, Swails T, Riggs T. Hypertriglyceridemia in extremely low birth weight infants receiving lipid emulsions. J Neonatal Perinat Med. 2015;8:133\u20136.","journal-title":"J Neonatal Perinat Med"},{"key":"2865_CR32","doi-asserted-by":"publisher","first-page":"179","DOI":"10.1016\/S0031-3955(16)34975-6","volume":"33","author":"MC Walsh","year":"1986","unstructured":"Walsh MC, Kliegman RM. Necrotizing enterocolitis: treatment based on staging criteria. Pediatr Clin North Am. 1986;33:179\u2013201.","journal-title":"Pediatr Clin North Am"},{"key":"2865_CR33","doi-asserted-by":"crossref","unstructured":"The International Classification of Retinopathy of Prematurity revisited. Arch Ophthalmol. 2005;123:991\u20139.","DOI":"10.1001\/archopht.123.7.991"},{"key":"2865_CR34","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1016\/S0022-3476(78)80282-0","volume":"92","author":"LA Papile","year":"1978","unstructured":"Papile LA, Burstein J, Burstein R, Koffler H. Incidence and evolution of subependymal and intraventricular hemorrhage: a study of infants with birth weights less than 1,500 gm. J Pediatr. 1978;92:529\u201334.","journal-title":"J Pediatr"},{"key":"2865_CR35","doi-asserted-by":"publisher","first-page":"543","DOI":"10.1111\/ppe.70035","volume":"39","author":"TR Fenton","year":"2025","unstructured":"Fenton TR, Elmrayed S, Alshaikh BN. Fenton third-generation growth charts of preterm infants without abnormal fetal growth: a systematic review and meta-analysis. Paediatr Perinat Epidemiol. 2025;39:543\u201355.","journal-title":"Paediatr Perinat Epidemiol"},{"key":"2865_CR36","doi-asserted-by":"publisher","first-page":"1084","DOI":"10.1002\/jpen.1138","volume":"42","author":"E Landau-Crangle","year":"2018","unstructured":"Landau-Crangle E, Rochow N, Fenton TR, Liu K, Ali A, So HY, et al. Individualized postnatal growth trajectories for preterm infants. J Parenter Enter Nutr. 2018;42:1084\u201392.","journal-title":"J Parenter Enter Nutr"},{"key":"2865_CR37","doi-asserted-by":"publisher","first-page":"3615","DOI":"10.1016\/j.tjnut.2024.10.005","volume":"154","author":"SA Abrams","year":"2024","unstructured":"Abrams SA, Ernst KD, Weitkamp JH, Mascarenhas M, Anderson-Berry A, Rudolph J, et al. Safety and efficacy of a composite lipid emulsion with fish oil in hospitalized neonates and infants requiring prolonged parenteral nutrition - a randomized, double-blind, multicenter, controlled trial. J Nutr. 2024;154:3615\u201325.","journal-title":"J Nutr"},{"key":"2865_CR38","first-page":"e1813","volume":"41","author":"S Costa","year":"2023","unstructured":"Costa S, Cocca C, D\u2019Apolito G, De Gisi A, Fattore S, Tataranno ML, et al. Effects of a multicomponent lipid emulsion on brain volumes in extremely low birth weight infants. Am J Perinatol. 2023;41:e1813\u20139.","journal-title":"Am J Perinatol"},{"key":"2865_CR39","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1055\/s-0039-1692390","volume":"37","author":"A Bin-Nun","year":"2020","unstructured":"Bin-Nun A, Kassirer Y, Mimouni FB, Shchors I, Hammerman C. Head circumference growth is enhanced by SMO flipid in preterm neonates. Am J Perinatol. 2020;37:1130\u20133.","journal-title":"Am J Perinatol"},{"key":"2865_CR40","doi-asserted-by":"publisher","first-page":"686","DOI":"10.1186\/s12887-024-05153-8","volume":"24","author":"MM Al-Mouqdad","year":"2024","unstructured":"Al-Mouqdad MM, Alshaikh B, Sumaily HH, Alodhaidan NA, AlMahmoud L, Almotiri AA, et al. Association between SMOFlipid and impaired brain development on term-equivalent age brain magnetic resonance imaging in very preterm infants. BMC Pediatr. 2024;24:686.","journal-title":"BMC Pediatr"},{"key":"2865_CR41","doi-asserted-by":"publisher","DOI":"10.3389\/fnut.2026.1723062","volume":"13","author":"S Caruggi","year":"2026","unstructured":"Caruggi S, Calandrino A, Corradi B, Battaglini M, Massirio P, Vinci F, et al. Do different lipid emulsions affect brain development? A single-center retrospective analysis. Front Nutr. 2026;13:1723062.","journal-title":"Front Nutr"},{"key":"2865_CR42","doi-asserted-by":"publisher","first-page":"1314","DOI":"10.1002\/jpen.1153","volume":"42","author":"J-C Lavoie","year":"2018","unstructured":"Lavoie J-C, Mohamed I, Nuyt A-M, Elremaly W, Rouleau T. Impact of SMOF lipid on pulmonary alveolar development in newborn guinea pigs. J Parenter Enter Nutr. 2018;42:1314\u201321.","journal-title":"J Parenter Enter Nutr"},{"key":"2865_CR43","doi-asserted-by":"publisher","first-page":"F27","DOI":"10.1136\/archdischild-2024-327606","volume":"111","author":"D Dang","year":"2026","unstructured":"Dang D, Gao Z, Zhang C, Mu X, Lv X, Wu H. Effect of enteral supplementation of DHA with or without ARA in preterm infants: a meta-analysis. Arch Dis Child Fetal Neonatal Ed. 2026;111:F27\u201333.","journal-title":"Arch Dis Child Fetal Neonatal Ed"},{"key":"2865_CR44","doi-asserted-by":"crossref","unstructured":"Wackernagel D, Nilsson AK, Sj\u00f6bom U, Hellstr\u00f6m A, Klevebro S, Hansen-Pupp I. Enteral supplementation with arachidonic and docosahexaenoic acid and pulmonary outcome in extremely preterm infants. Prostaglandins Leukot Essent Fatty Acids. 2024;201:102613.","DOI":"10.1016\/j.plefa.2024.102613"},{"key":"2865_CR45","doi-asserted-by":"publisher","first-page":"2377","DOI":"10.1002\/ppul.24938","volume":"55","author":"A Correani","year":"2020","unstructured":"Correani A, Dell\u2019Orto V, Nobile S, Antognoli L, Marchionni P, Giretti I, et al. Oxygen saturation to fraction of inspired oxygen ratio in preterm infants on routine parenteral nutrition with conventional or fish oil containing lipid emulsions. Pediatr Pulmonol. 2020;55:2377\u201382.","journal-title":"Pediatr Pulmonol"},{"key":"2865_CR46","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.jpeds.2017.11.012","volume":"194","author":"A Repa","year":"2018","unstructured":"Repa A, Binder C, Thanhaeuser M, Kreissl A, Pablik E, Huber-Dangl M, et al. A mixed lipid emulsion for prevention of parenteral nutrition associated cholestasis in extremely low birth weight infants: a randomized clinical trial. J Pediatr. 2018;194:87\u201393.e81.","journal-title":"J Pediatr"},{"key":"2865_CR47","first-page":"Cd013163","volume":"6","author":"V Kapoor","year":"2019","unstructured":"Kapoor V, Malviya MN, Soll R. Lipid emulsions for parenterally fed preterm infants. Cochrane Database Syst Rev. 2019;6:Cd013163.","journal-title":"Cochrane Database Syst Rev"},{"key":"2865_CR48","doi-asserted-by":"publisher","DOI":"10.1002\/mnfr.202400752","volume":"69","author":"M Bodur","year":"2025","unstructured":"Bodur M, Yilmaz B, A\u011fag\u00fcnd\u00fcz D, Ozogul Y. Immunomodulatory effects of omega-3 fatty acids: mechanistic insights and health implications. Mol Nutr Food Res. 2025;69:e202400752.","journal-title":"Mol Nutr Food Res"},{"key":"2865_CR49","doi-asserted-by":"publisher","first-page":"2769","DOI":"10.1093\/jn\/137.12.2769","volume":"137","author":"N-T Luu","year":"2007","unstructured":"Luu N-T, Madden J, Calder PC, Grimble RF, Shearman CP, Chan T, et al. Dietary supplementation with fish oil modifies the ability of human monocytes to induce an inflammatory response. J Nutr. 2007;137:2769\u201374.","journal-title":"J Nutr"},{"key":"2865_CR50","doi-asserted-by":"publisher","first-page":"H811","DOI":"10.1152\/ajpheart.00235.2002","volume":"283","author":"K Mayer","year":"2002","unstructured":"Mayer K, Merfels M, Muhly-Reinholz M, Gokorsch S, Rosseau S, Lohmeyer J, et al. \u03c9-3 Fatty acids suppress monocyte adhesion to human endothelial cells: role of endothelial PAF generation. Am J Physiol Heart Circ Physiol. 2002;283:H811\u20138.","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"2865_CR51","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1203\/pdr.0b013e318045bec9","volume":"61","author":"AT Hsieh","year":"2007","unstructured":"Hsieh AT, Anthony JC, Diersen-Schade DA, Rumsey SC, Lawrence P, Li C, et al. The influence of moderate and high dietary long chain polyunsaturated fatty acids (LCPUFA) on baboon neonate tissue fatty acids. Pediatr Res. 2007;61:537\u201345.","journal-title":"Pediatr Res"}],"container-title":["Journal of Perinatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02865-w","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02865-w.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T09:03:51Z","timestamp":1791450231000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41372-026-02865-w"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10,8]]},"references-count":51,"alternative-id":["2865"],"URL":"https:\/\/doi.org\/10.1038\/s41372-026-02865-w","relation":{},"ISSN":["0743-8346","1476-5543"],"issn-type":[{"value":"0743-8346","type":"print"},{"value":"1476-5543","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,10,8]]},"assertion":[{"value":"27 February 2026","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 July 2026","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"31 July 2026","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 October 2026","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Ethics"}},{"value":"All methods were performed in accordance with the relevant guidelines and regulations of respective IRB boards from NYU Langone and University Hospitals. No informed consent was necessary to be obtained; the study protocol was reviewed and approved as exempt by the institutional review boards of both participating institutions \u2013 NYU IRB protocol s24-00105 and RBC protocol STUDY20241092.","order":2,"name":"Ethics","label":"Ethics approval and consent to participate","group":{"name":"EthicsHeading","label":"Ethics"}}]}}